HK Stock MarketDetailed Quotes

08189 TEDA BIOMEDICAL

Watchlist

0.075
0.0000.00%

Not Open Apr 25 16:09 CST

142.09MMarket Cap-6250P/E (TTM)

TEDA BIOMEDICAL Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

(FY)Dec 31, 2021

(Q9)Sep 30, 2021

Turnover

-1.42%398M

0.08%305.23M

-9.40%185.92M

-3.11%86.42M

-15.25%403.73M

-14.61%304.97M

-15.13%205.21M

-28.30%89.2M

28.98%476.38M

41.94%357.14M

Operating income

-1.42%398M

0.08%305.23M

-9.40%185.92M

-3.11%86.42M

-15.25%403.73M

-14.61%304.97M

-15.13%205.21M

-28.30%89.2M

28.98%476.38M

41.94%357.14M

Cost of sales

3.16%-376.63M

0.02%-293.73M

8.10%-179.07M

0.40%-83.37M

9.72%-388.91M

7.76%-293.78M

8.84%-194.84M

24.37%-83.71M

-30.95%-430.78M

-39.43%-318.51M

Operating expenses

3.16%-376.63M

0.02%-293.73M

8.10%-179.07M

0.40%-83.37M

9.72%-388.91M

7.76%-293.78M

8.84%-194.84M

24.37%-83.71M

-30.95%-430.78M

-39.43%-318.51M

Gross profit

44.15%21.37M

2.79%11.5M

-33.96%6.85M

-44.40%3.05M

-67.50%14.82M

-71.03%11.19M

-63.05%10.37M

-59.99%5.49M

12.91%45.6M

66.67%38.63M

Selling expenses

22.96%-8.1M

25.74%-6.96M

35.00%-5.28M

28.86%-3.03M

39.17%-10.52M

45.01%-9.37M

38.11%-8.12M

45.54%-4.26M

-3.69%-17.29M

-18.49%-17.04M

Administrative expenses

3.93%-21.8M

----

27.87%-22.7M

----

-33.00%-31.47M

----

Research and development expenses

-16.09%-1.32M

4.17%-21.54M

-12.51%-13.77M

-3.66%-6.86M

67.52%-1.14M

-19.72%-22.48M

14.27%-12.24M

11.18%-6.62M

36.57%-3.5M

14.71%-18.77M

Profit from asset sales

----

--5.91M

----

Impairment and provision

-115.00%-11.18M

----

86.25%-5.2M

----

-9.71%-37.84M

----

-Impairment of intangible assets

----

-17.58%-1.84M

----

-Impairment of property, machinery and equipment

----

---3.16M

----

-Goodwill impairment

----

94.74%-420K

----

-Other impairment is provision

-115.00%-11.18M

----

83.96%-5.2M

----

-29.97%-32.42M

----

Special items of operating profit

1,120.52%14.2M

-116.09%-467.57K

-261.17%-415.76K

-401.43%-80.09K

-71.75%1.16M

387.72%2.91M

-35.45%257.97K

-81.13%26.57K

163.61%4.12M

128.34%595.67K

Operating profit

61.26%-6.84M

1.61%-17.47M

-29.65%-12.62M

-28.98%-6.92M

56.27%-17.65M

-620.45%-17.75M

-1,012.47%-9.73M

-278.08%-5.37M

13.04%-40.37M

122.27%3.41M

Financing cost

19.19%-5.17M

38.10%-2.54M

54.32%-1.52M

-5.24%-781.54K

-17.09%-6.4M

-189.21%-4.1M

-353.06%-3.33M

-914.12%-742.59K

-234.19%-5.47M

-44.79%-1.42M

Share of profits of associates

----

151.64%1M

----

Adjustment items of earning before tax

----

--2

----

Earning before tax

50.06%-12.01M

8.46%-20M

-8.24%-14.14M

-26.10%-7.71M

46.35%-24.06M

-1,196.40%-21.85M

-4,041.55%-13.06M

-309.27%-6.11M

10.32%-44.84M

112.23%1.99M

Tax

105.86%1.04M

128.30%41.39K

---724

827.00%507.1K

-278.21%-146.28K

-360.02%-146.28K

----

115.08%54.7K

122.74%82.08K

After-tax profit from continuing operations

53.42%-10.97M

9.26%-19.96M

-6.73%-14.1M

-26.11%-7.71M

47.42%-23.55M

-1,160.09%-22M

-3,507.31%-13.21M

-309.27%-6.11M

11.08%-44.78M

112.46%2.08M

After-tax profit from non-continuing business

-129.28%-5.6M

----

---2.44M

----

Earning after tax

36.25%-16.57M

9.26%-19.96M

-6.73%-14.1M

-26.11%-7.71M

41.96%-25.99M

-1,160.09%-22M

-3,507.31%-13.21M

-309.27%-6.11M

11.08%-44.78M

112.46%2.08M

Minority shareholders should account for profits from continuing business

145.81%3.59M

----

--1.46M

----

Minority profit

145.81%3.59M

-617.87%-2.67M

-7,358.70%-2.85M

-2,595.50%-1.83M

157.73%1.46M

-247.70%-371.67K

109.30%39.23K

94.89%-67.91K

-6.95%-2.53M

133.78%251.65K

Shareholders should account for profits from continuing business

41.79%-14.56M

----

---25.01M

----

Shareholders should account for profits from non-continuing business

-129.28%-5.6M

----

---2.44M

----

Profit attributable to shareholders

26.56%-20.16M

20.03%-17.29M

15.08%-11.25M

2.76%-5.88M

35.03%-27.45M

-1,286.00%-21.63M

-1,736.47%-13.25M

-3,548.93%-6.04M

11.97%-42.26M

111.46%1.82M

Basic earnings per share

26.90%-0.0106

20.18%-0.0091

15.71%-0.0059

3.13%-0.0031

34.98%-0.0145

-1,240.00%-0.0114

-1,850.00%-0.007

-3,100.00%-0.0032

11.86%-0.0223

111.90%0.001

Diluted earnings per share

26.90%-0.0106

-0.0145

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Fan Chen Certified Public Accountants Ltd

	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022	(FY)Dec 31, 2021	(Q9)Sep 30, 2021
Turnover	-1.42%398M	0.08%305.23M	-9.40%185.92M	-3.11%86.42M	-15.25%403.73M	-14.61%304.97M	-15.13%205.21M	-28.30%89.2M	28.98%476.38M	41.94%357.14M
Operating income	-1.42%398M	0.08%305.23M	-9.40%185.92M	-3.11%86.42M	-15.25%403.73M	-14.61%304.97M	-15.13%205.21M	-28.30%89.2M	28.98%476.38M	41.94%357.14M
Cost of sales	3.16%-376.63M	0.02%-293.73M	8.10%-179.07M	0.40%-83.37M	9.72%-388.91M	7.76%-293.78M	8.84%-194.84M	24.37%-83.71M	-30.95%-430.78M	-39.43%-318.51M
Operating expenses	3.16%-376.63M	0.02%-293.73M	8.10%-179.07M	0.40%-83.37M	9.72%-388.91M	7.76%-293.78M	8.84%-194.84M	24.37%-83.71M	-30.95%-430.78M	-39.43%-318.51M
Gross profit	44.15%21.37M	2.79%11.5M	-33.96%6.85M	-44.40%3.05M	-67.50%14.82M	-71.03%11.19M	-63.05%10.37M	-59.99%5.49M	12.91%45.6M	66.67%38.63M
Selling expenses	22.96%-8.1M	25.74%-6.96M	35.00%-5.28M	28.86%-3.03M	39.17%-10.52M	45.01%-9.37M	38.11%-8.12M	45.54%-4.26M	-3.69%-17.29M	-18.49%-17.04M
Administrative expenses	3.93%-21.8M	----	----	----	27.87%-22.7M	----	----	----	-33.00%-31.47M	----
Research and development expenses	-16.09%-1.32M	4.17%-21.54M	-12.51%-13.77M	-3.66%-6.86M	67.52%-1.14M	-19.72%-22.48M	14.27%-12.24M	11.18%-6.62M	36.57%-3.5M	14.71%-18.77M
Profit from asset sales	----	----	----	----	--5.91M	----	----	----	----	----
Impairment and provision	-115.00%-11.18M	----	----	----	86.25%-5.2M	----	----	----	-9.71%-37.84M	----
-Impairment of intangible assets	----	----	----	----	----	----	----	----	-17.58%-1.84M	----
-Impairment of property, machinery and equipment	----	----	----	----	----	----	----	----	---3.16M	----
-Goodwill impairment	----	----	----	----	----	----	----	----	94.74%-420K	----
-Other impairment is provision	-115.00%-11.18M	----	----	----	83.96%-5.2M	----	----	----	-29.97%-32.42M	----
Special items of operating profit	1,120.52%14.2M	-116.09%-467.57K	-261.17%-415.76K	-401.43%-80.09K	-71.75%1.16M	387.72%2.91M	-35.45%257.97K	-81.13%26.57K	163.61%4.12M	128.34%595.67K
Operating profit	61.26%-6.84M	1.61%-17.47M	-29.65%-12.62M	-28.98%-6.92M	56.27%-17.65M	-620.45%-17.75M	-1,012.47%-9.73M	-278.08%-5.37M	13.04%-40.37M	122.27%3.41M
Financing cost	19.19%-5.17M	38.10%-2.54M	54.32%-1.52M	-5.24%-781.54K	-17.09%-6.4M	-189.21%-4.1M	-353.06%-3.33M	-914.12%-742.59K	-234.19%-5.47M	-44.79%-1.42M
Share of profits of associates	----	----	----	----	----	----	----	----	151.64%1M	----
Adjustment items of earning before tax	----	----	----	----	----	----	--2	----	----	----
Earning before tax	50.06%-12.01M	8.46%-20M	-8.24%-14.14M	-26.10%-7.71M	46.35%-24.06M	-1,196.40%-21.85M	-4,041.55%-13.06M	-309.27%-6.11M	10.32%-44.84M	112.23%1.99M
Tax	105.86%1.04M	128.30%41.39K	128.30%41.39K	---724	827.00%507.1K	-278.21%-146.28K	-360.02%-146.28K	----	115.08%54.7K	122.74%82.08K
After-tax profit from continuing operations	53.42%-10.97M	9.26%-19.96M	-6.73%-14.1M	-26.11%-7.71M	47.42%-23.55M	-1,160.09%-22M	-3,507.31%-13.21M	-309.27%-6.11M	11.08%-44.78M	112.46%2.08M
After-tax profit from non-continuing business	-129.28%-5.6M	----	----	----	---2.44M	----	----	----	----	----
Earning after tax	36.25%-16.57M	9.26%-19.96M	-6.73%-14.1M	-26.11%-7.71M	41.96%-25.99M	-1,160.09%-22M	-3,507.31%-13.21M	-309.27%-6.11M	11.08%-44.78M	112.46%2.08M
Minority shareholders should account for profits from continuing business	145.81%3.59M	----	----	----	--1.46M	----	----	----	----	----
Minority profit	145.81%3.59M	-617.87%-2.67M	-7,358.70%-2.85M	-2,595.50%-1.83M	157.73%1.46M	-247.70%-371.67K	109.30%39.23K	94.89%-67.91K	-6.95%-2.53M	133.78%251.65K
Shareholders should account for profits from continuing business	41.79%-14.56M	----	----	----	---25.01M	----	----	----	----	----
Shareholders should account for profits from non-continuing business	-129.28%-5.6M	----	----	----	---2.44M	----	----	----	----	----
Profit attributable to shareholders	26.56%-20.16M	20.03%-17.29M	15.08%-11.25M	2.76%-5.88M	35.03%-27.45M	-1,286.00%-21.63M	-1,736.47%-13.25M	-3,548.93%-6.04M	11.97%-42.26M	111.46%1.82M
Basic earnings per share	26.90%-0.0106	20.18%-0.0091	15.71%-0.0059	3.13%-0.0031	34.98%-0.0145	-1,240.00%-0.0114	-1,850.00%-0.007	-3,100.00%-0.0032	11.86%-0.0223	111.90%0.001
Diluted earnings per share	26.90%-0.0106				-0.0145
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--
Auditor	Fan Chen Certified Public Accountants Ltd	--	--	--	Fan Chen Certified Public Accountants Ltd	--	--	--	Fan Chen Certified Public Accountants Ltd	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

08189 TEDA BIOMEDICAL

TEDA BIOMEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target